Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 3 Issue: 4, November

Editorial [ The Role of Epidermal Growth Factor Receptor (EGFR) Targeting Drugs in the Treatment of Cancer Guest Editor: Fortunato Ciardiello ]

Volume:3   Issue: 4
Pp: 223-225
Fortunato Ciardiello and Giampaolo Tortora
DOI: 10.2174/157339407782497040
Published on: 01 March, 2012

Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment

Volume:3   Issue: 4
Pp: 226-235
Clorinda Schettino, Maria Anna Bareschino, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli
DOI: 10.2174/157339407782496997
Published on: 01 March, 2012

Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity

Volume:3   Issue: 4
Pp: 236-241
Teresa Troiani, Tina Cascone, John Heymach and Fortunato Ciardiello
DOI: 10.2174/157339407782496979
Published on: 01 March, 2012

Cetuximab, A Chimeric Anti-Epidermal Growth Factor Receptor Monoclonal Antibody, in Colorectal Cancer Treatment

Volume:3   Issue: 4
Pp: 242-248
Erika Martinelli, Michele Orditura, Ferdinando De Vita, Gennaro Galizia and Fortunato Ciardiello
DOI: 10.2174/157339407782497068
Published on: 01 March, 2012

Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab

Volume:3   Issue: 4
Pp: 249-254
Andrea Sartore-Bianchi, Andrea Sporchia, Giulio Cerea, Maria Rosaria Maugeri, Tiziana Cipani, Ines Andreotti, Giovanna Marrapese, Salvatore Artale and Salvatore Siena
DOI: 10.2174/157339407782497022
Published on: 01 March, 2012

EGFR Inhibitors and Radiation in HNSCC

Volume:3   Issue: 4
Pp: 255-266
Laura QM Chow, Changhu Chen and David Raben
DOI: 10.2174/157339407782497004
Published on: 01 March, 2012

Optimizing Anti-EGFR Strategies in Cancer Treatment

Volume:3   Issue: 4
Pp: 267-275
Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro and Federico Cappuzzo
DOI: 10.2174/157339407782497059
Published on: 01 March, 2012

Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors

Volume:3   Issue: 4
Pp: 276-283
Floriana Morgillo, Giampaolo Tortora and Fortunato Ciardiello
DOI: 10.2174/157339407782496988
Published on: 01 March, 2012

Combination of Anti-EGFR Drugs with Anti-Angiogenic or Other Signal Transduction Inhibitors as a Rational Approach to Cancer Therapy

Volume:3   Issue: 4
Pp: 284-291
Maria Pia Morelli, Jennifer Spratlin and S. Gail Eckhardt
DOI: 10.2174/157339407782497013
Published on: 01 March, 2012

Methodological Issues of Clinical Research with EGFR Inhibitors

Volume:3   Issue: 4
Pp: 292-302
Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, Fabiano Falasconi, Nicola Normanno and Francesco Perrone
DOI: 10.2174/157339407782497031
Published on: 01 March, 2012